Found 658 matching trials
Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics. PHASE2 People with asthma suffer from breathlessness because the small tubes (bron...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD PHASE2 The overall objective of this study was to assess the efficacy and safety o...
Show More Location
Pearl Investigative Site
Learn More & Join Trial
New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma PHASE3 The purpose of this study is to compare the efficacy and safety of the fixe...
Show More Learn More & Join Trial
BI 671800 in Asthmatic Patients on Inhaled Corticosteroids PHASE2 This is a 6 week study to assess the effect of BI 671800 in patients with a...
Show More Location
1268.16.01004 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study was designed to investigate the 1 year efficacy and safety of th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma PHASE3 The overall purpose of the trial is to evaluate efficacy and safety of tiot...
Show More Location
205.456.01004 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration PHASE1 The purpose of this study is to evaluate the safety and the efficacy of Gly...
Show More Location
Medicines Evaluation Unit
Learn More & Join Trial
GSK159802 In Healthy Male Subjects And Asthmatics PHASE1 GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma PHASE2 The primary objective of this study is to determine the optimum dose(s) of ...
Show More Location
1222.6.064 Arthur F. Gelb Medical Corporation, Lakewood
Learn More & Join Trial
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients PHASE3 The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Show More Location
Combined Research Orlando
Learn More & Join Trial